Lifecore Biomedical Inc. share price logo

Lifecore Biomedical Inc. Share Price

NASDAQ: LFCR

Small Cap

$4.92

(+-0.10%)

Live

as on

Lifecore Biomedical Inc. Stock Performance

as on April 25, 2026 at 2:12 am IST

  • Day's Low

    Day's High

    $4.75
    $5.01
    downward going graph

    3.46%

    Downside

    1.83%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.63
    $8.98
    downward going graph

    26.32%

    Downside

    82.52%

    Upside

    downward going graph

Lifecore Biomedical Inc. share price movements today

Previous Close
$4.92
Open
$4.94
Volume
150.2K
Day's Low - High
$4.75 - $5.01
52 Week Low - High
$3.63 - $8.98

Lifecore Biomedical Inc. Historical Returns

1 Month Return
+ 23 %
3 Month Return
-42.66 %
1 Year Return
-20.26 %
3 Year Return
+ 12.84 %
5 Year Return
0 %

Lifecore Biomedical Inc. Stock Fundamentals & Key Indicators

Check Lifecore Biomedical Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$184.4M

EPS (TTM)

-0.84

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

2.6609

EBITDA

8.2M

Revenue (TTM)

129.5M

Profit Margin

-23.78%

Return On Equity TTM

-76.41%

Lifecore Biomedical Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lifecore Biomedical Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$184.4MNANA-23.78%
BUY$25.1BNA20.5741.94%
HOLD$16.9B10.4%NA-24.58%
BUY$42.4BNA19.0615.11%
BUY$49.0B-31.95%19.2828.24%

Stock Returns calculator for Lifecore Biomedical Inc. Stock including INR - Dollar returns

The Lifecore Biomedical Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lifecore Biomedical Inc. investment value today

Current value as on today

₹88,060

Returns

-₹11,940

(-11.94%)

Returns from Lifecore Biomedical Inc. Stock

-₹20,259 (-20.26%)

Dollar Impact

₹8,320 (+8.32%)

Analyst Recommendation on Lifecore Biomedical Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Lifecore Biomedical Inc.. Average target price of $6.5

Lifecore Biomedical Inc. Share Price Target

Get share price movements and forecasts by analysts on Lifecore Biomedical Inc..

What analysts predicted

24.31%UPSIDE

Target Price

$6.5

Current Price

$4.92

Analyzed by

6 Analysts

Target

$6.50

Lifecore Biomedical Inc. target price $6.5, a slight upside of 24.31% compared to current price of $4.92. According to 6 analysts rating.

Lifecore Biomedical Inc. Stock’s Investor Sentiment and Interest

Search interest for Lifecore Biomedical Inc. Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Lifecore Biomedical Inc. Quarterly Profit & Loss

All numbers in Millions USD

Aug 2023
Nov 2023
Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Feb 2026
Total Revenue
24
30
25
37
24
32
35
36
31
44
Gross Profit
2
9
8
17
5
11
9
13
7
15
Operating Income
-8
-1
-1
2
-11
-1
-9
5
-3
2
EBITDA
-
-
-22
0
-8
0
-7
6
-7
5
Interest Expense
3
4
3
5
5
5
5
5
0
9
Depreciation
2
1
2
2
1
2
2
1
1
-
Income Before Tax
-12
14
-29
-7
-16
-6
-14
-1
-9
-7
Income Tax Expense
-
-
0
0
0
0
0
0
0
0
Net Income
-10
14
-35
-7
-16
-6
-14
-1
-9
-7
Net Profit Margin
-43.85%
47.16%
-139.38%
-18.70%
-65.70%
-20.18%
-42.01%
-3.15%
-32.12%
-17.95%

Lifecore Biomedical Inc. Annual Profit & Loss

All numbers in Millions USD

May 2016
May 2017
May 2018
May 2019
May 2020
May 2021
May 2022
May 2023
May 2024
May 2025
Total Revenue
541
532
524
557
160
100
185
111
128
128
Gross Profit
70
83
78
81
39
38
50
39
41
40
Operating Income
-19
15
11
-8
-25
-8
-3
-11
-8
-17
EBITDA
-7
26
24
23
-7
0
-68
12
35
-8
Interest Expense
1
1
1
5
4
8
17
15
18
21
Depreciation
-
-
-
15
18
19
17
13
8
8
Income Before Tax
-18
15
16
3
-30
-29
-52
-20
9
-38
Income Tax Expense
-7
4
-9
1
-8
-6
-5
-5
0
0
Net Income
-11
10
24
2
-38
-32
-97
-116
12
-38
Net Profit Margin
-2.15%
1.99%
4.74%
0.38%
-23.86%
-32.01%
-52.44%
-104.89%
9.37%
-30.04%

Lifecore Biomedical Inc. Quarterly Cash Flow

All numbers in Millions USD

Nov 2023
Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Feb 2026
Net Income
14
-35
-7
-16
-6
-14
-1
-9
-7
Operating Cash Flow
1
0
8
0
-6
1
5
1
5
Investing Cash Flow
-
-8
-2
-3
-2
1
-2
-1
8
Financing Cash Flow
-2
24
0
1
12
-6
0
-1
-3
Change in Cash
-5
16
5
-2
3
-4
2
-1
-1

Lifecore Biomedical Inc. Annual Cash Flow

All numbers in Millions USD

May 2017
May 2018
May 2019
May 2020
May 2021
May 2022
May 2023
May 2024
May 2025
Net Income
10
24
0
-15
-32
-97
-116
12
-38
Operating Cash Flow
29
19
16
-17
16
-24
-22
0
0
Investing Cash Flow
-25
-35
-96
-23
-12
81
79
-18
-6
Financing Cash Flow
-8
13
79
40
-3
-57
-57
7
6
Change in Cash
-4
-2
-1
0
0
0
0
-10
0

Global Institutional Holdings in Lifecore Biomedical Inc.

Funds
Holdings
UBS Group AG
0.25%
Wynnefield Capital Inc
12.55%
Charles Schwab Investment Management Inc
0.23%
BlackRock Inc
4.91%
Vanguard Group Inc
4.47%

Insights on Lifecore Biomedical Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -9.99M → -7.97M (in $), with an average increase of 25.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 31.10M → 44.41M (in $), with an average increase of 30.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 93.3% return, outperforming this stock by 113.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 150.9% return, outperforming this stock by 138.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, LFCR stock has moved down by -42.7%

About Lifecore Biomedical Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
OrganisationLifecore Biomedical Inc.
Headquarters3515 Lyman Boulevard, Chaska, MN, United States, 55318
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Paul Josephs
E-voting on sharesClick here to vote

Key Management of Lifecore Biomedical Inc.

Name

Title

Ms. Jackie Q. Klecker

Executive Vice President of Quality & Development Services

Mr. Parker K. Javid

Vice President

Mr. Paul Josephs

President, CEO & Director

Mr. Ryan D. Lake CPA

Executive VP & CFO

Mr. Thomas D. Salus

Chief Legal & Administration Officer and Corporate Secretary

Mr. Thomas Guldager

Senior Vice President of Operations

Mr. Aaron Perlitsh

Director of Internal Audit & Chief Compliance Officer

FAQs

What is Lifecore Biomedical Inc. share price today?

Lifecore Biomedical Inc. share price today is $4.92 as on . Lifecore Biomedical Inc. share today touched a day high of $5.01 and a low of $4.75.

What is the 52 week high and 52 week low for Lifecore Biomedical Inc. share?

Lifecore Biomedical Inc. share touched a 52 week high of $8.98 on and a 52 week low of $3.63 on . Lifecore Biomedical Inc. stock price today i.e. is trending at $4.92,which is 45.21% down from its 52 week high and 35.72% up from its 52 week low.

What is Lifecore Biomedical Inc.'s market capitalisation today?

Lifecore Biomedical Inc. market capitalisation is $0.00T as on .

How to invest in Lifecore Biomedical Inc. Stock (LFCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lifecore Biomedical Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lifecore Biomedical Inc. Shares that will get you 0.3049 shares as per Lifecore Biomedical Inc. share price of $4.92 per share as on April 24, 2026 at 8:42 pm IST.

What is the minimum amount required to buy Lifecore Biomedical Inc. Stock (LFCR) from India?

Indian investors can start investing in Lifecore Biomedical Inc. (LFCR) shares with as little as ₹94.228 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Lifecore Biomedical Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Lifecore Biomedical Inc. share’s latest price of $4.92 as on April 24, 2026 at 8:42 pm IST, you will get 2.0325 shares of Lifecore Biomedical Inc.. Learn more about fractional shares .